Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adaptive Group
Seattle, Washington, United Statesadaptivegroup.com ↗
- Ownership
- Private
- Employees
- ~761
- Development stage
- Other
01
Overview
Adaptive Biotechnologies has commercialized several products including clonoSEQ®—an FDA-cleared NGS-based diagnostic for measurable residual disease in multiple myeloma, B‑ALL, CLL, and other blood cancers. The company also offers immunoSEQ® for research use to profile immune repertoires. Its clinical pipeline includes further expansion of MRD testing applications and partnerships to develop new diagnostics in oncology and infectious diseases. Recent results include expanded Medicare coverage for clonoSEQ in mantle cell lymphoma patients as of April 2025[4].
- Therapeutic areas
- Infectious DiseasesImmunologyOncology
- Modalities
- Diagnostic test (NGS-based)Platform technology for T-cell receptor and B-cell receptor sequencing
- Industry
- Molecular Diagnostics
02
Partnerships
NeoGenomicsMultiple biopharmaceutical companies
Beyond the preview
Go deeper on Adaptive Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adaptive Group.